Zoetis | Des Atouts



Assets Changement Date
AbbVie USD 135.16B 8.26B 2024-12
Align Technology USD 6.21B 151.37M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Dentsply International USD 5.75B 873M 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Henry Schein USD 10.22B 387M 2024-12
Idexx Laboratories USD 3.29B 57.32M 2024-12
Illumina USD 6.3B 289M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
J&J USD 180.1B 1.82B 2024-12
Laboratory Of America USD 18.38B 233.5M 2024-12
Merck USD 117.11B 426M 2024-12
Neogen USD 4.05B 449.08M 2024-11
Pacira USD 1.55B 31.82M 2024-12
Patterson Companies USD 2.83B 13.02M 2025-01
Perrigo USD 9.65B 1.56B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Quest Diagnostics USD 16.15B 58M 2024-12
Sanofi 129.76B 3.29B 2024-06
Sanofi 129.76B 3.29B 2024-06
Zoetis USD 14.24B 120M 2024-12



Zoetis Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.